XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 37.73

Change

+0.09 (+0.24)%

Market Cap

CAD 0.45B

Volume

1.95K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+1.24 (+1.01%)

CAD 12.96B
ZSP:CA BMO S&P 500

+0.74 (+0.98%)

CAD 12.96B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.54 (+1.01%)

CAD 9.55B
VUN:CA Vanguard US Total Market

+0.94 (+1.02%)

CAD 7.86B
XUS:CA iShares Core S&P 500 Index ETF

+0.92 (+1.07%)

CAD 5.82B
HXS:CA Horizons S&P 500 Index ETF

+0.75 (+1.07%)

CAD 3.33B
VSP:CA Vanguard S&P 500 CAD hedged

+0.84 (+1.02%)

CAD 2.98B
QUU:CA Mackenzie US Large Cap Equity ..

+1.77 (+0.89%)

CAD 2.89B
XUU:CA iShares Core S&P US Total Mark..

+0.49 (+0.96%)

CAD 2.66B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+2.04 (+1.54%)

CAD 2.54B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.90% 86% B+ 82% B
Dividend Return 0.23% 20% F 6% D-
Total Return 13.12% 90% A- 81% B-
Trailing 12 Months  
Capital Gain 29.21% 72% C 85% B
Dividend Return 1.30% 38% F 24% F
Total Return 30.52% 74% C 85% B
Trailing 5 Years  
Capital Gain 89.12% 86% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.12% 76% C+ 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.92% 87% B+ 81% B-
Dividend Return 12.59% 84% B 80% B-
Total Return 0.66% 16% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 13.86% 49% F 58% F
Risk Adjusted Return 90.79% 75% C 97% N/A
Market Capitalization 0.45B 65% D 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.